Match Document Document Title
DE102005063244A1 New 2-nitroimidazole derivatives, useful for detecting hypoxic tissue especially associated with tumors, diabetes, stroke and/or circulatory diseases, have substituent that mediates transport into biological cells  
New 2-nitroimidazole derivatives (I) have a substituent (or vehicle) that mediates transport into biological cells via cellular transport systems. Independent claims are also included for the...
DE102005059242A1 Molecular markers for tumor diagnosis and therapy  
The This invention relates to the diagnosis, prognosis, monitoring and therapy of neoplastic diseases such as tumor diseases, in particular Cancers of the endometrium and their metastases.
DE102005058542A1 Erythruloseester as UV filters  
The Invention relates to compounds according to formula I, wherein X, Y and Z are O, NH or N-alkyl, Sp, Sp ', Sp' 'can be identical or different and are -H, - (CH2)n-, - (CH2)n-C (= O) - (CH2)O-...
DE102005058431A1 Nucleic acid useful as a target for detecting species of yeasts and/or filamentous fungi comprises an elongation factor 3 gene or a fragment thereof  
Nucleic acid (I) comprising the elongation factor 3 gene of yeasts and filamentous fungi or a fragment thereof is new. New nucleic acid (I) comprises a nucleic acid (Ia) with a sequence selected...
DE102005057334A1 A method for isolating nucleic acids from any starting materials  
object the invention is a universal and highly simplified procedure for isolating nucleic acids of nucleic acids containing diverse feedstocks using a combination from buffers with chaotropic...
DE102005046361A1 Detection and differentiation of Salmonella serovars, especially parathyphi B and Java, useful for analysis of e.g. food, clinical and water samples, based on amplification of gene STM3356  
Method for detecting and/or differentiating Salmonella serovars (A). Method for detecting and/or differentiating Salmonella serovars (A) comprises (i) amplifying a region of the STM3356 gene,...
DE102005047736B4 Method and system for isolating nucleic acids from any complex starting materials  
systems without chaotropic and antichaotropic components for isolating nucleic acids from nucleic acids containing materials comprising • at least a per se known Buffer for proteolytic digestion...
DE102005047736A1 Method to isolate nucleic acid comprises protectively solubilizing biological sample in buffer, adding alcoholic component/non ionic detergent, binding nucleic acid to solid phase, washing with buffer and eluting with salt buffer/water  
Method for isolation of nucleic acid from nucleic acid material comprises protectively solubilizing biological sample in a previously known buffer solution, which is provided with no chaotropic or...
DE102005033902B3 Perfluoroalkyl-containing complexes, processes for their preparation, and their use and pharmaceutical compositions containing them  
The Invention relates to the marked in the patent claims, namely perfluoroalkyl Metal complexes with nitrogen-containing groups of the general formula I, to processes for their preparation and...
DE102005046490A1 New nucleic acid molecule comprising promoter, a transcriptable nucleic acid sequence, a first and second nucleic acid sequence for producing modified RNA with transcriptional stability and translational efficiency  
Nucleic acid molecule comprising (in 5'-3' transcription direction) (a) a promoter; (b) a transcriptable nucleic acid sequence or a nucleic acid sequence for inserting in to a transcriptable...
DE102005042828A1 Selected CGPR antagonists, process for their preparation and their use as medicaments  
object the present invention relates to the CGRP-antagonists of general Formulas I, in which R1, R2 and R3 are as defined in claim 1, their Tautomers, the isomers, the diastereomers, deren...
DE112004002170T5 Improved methods and compositions for RNA interference  
process to weaken the expression of a target nucleotide sequence in a eukaryotic Cell, said method comprising: introducing double-stranded RNA (DsRNA) into the eukaryotic cell to the expression of...
DE102005040259A1 A process for recovering nucleic acids from blood  
The This invention relates to an improved process for isolating of nucleic acids in particular from genomic deoxyribonucleic acid (DNA) from blood.
DE102005035461A1 Stable NAD / NADH derivatives  
The Invention relates to stable nicotinamide adenine dinucleotide (NAD / NADH) - or nicotinamide adenine dinucleotide phosphate (NADP / NADPH) derivatives, Enzyme complexes of these derivatives...
DE102005036542A1 CTL prodrug  
The This invention relates to a polypeptide having preferably antitumoral and / or immunomodulatory Zytokineigenschaften through which Processing in vivo is activated, comprising a C-terminal...
DE102006035020A1 Test element for determining analytes, comprises stabilized coenzyme and coenzyme-dependent enzyme, used especially for determination of glucose  
A test element (A) for determination of an analyte comprises: (i) a coenzyme-dependent enzyme (E) or a substrate for E; and (ii) as a coenzyme, a stabilized NAD derivative (I), or its salts or...
DE102006012317A1 New macromolecular compounds comprising nucleotide and nucleoside building blocks, are useful in enzymatic reactions and nucleic acid analysis  
Macromolecular compounds (I) are new. Macromolecular compounds (I) of formula (Nuc-linker) n-marker, are new. Nuc : nucleotide or nucleoside; linker : a linker component, the Nuc components and...
DE102005033903B4 Perfluoroalkyl-containing complexes, processes for their preparation, and their use and pharmaceutical compositions containing them  
perfluoroalkyl Metal complexes having N-alkyl group of the general formula I in which R either one about 1-OH-bonded mono- or oligosaccharide represents the optional is peralkylated, in this case...
DE102005033903A1 New perfluoroalkyl-containing metal complexes, useful for production of contrast agents for use in e.g. NMR and X-ray diagnostics, necrosis imaging and in radiodiagnostics and radiotherapy  
Perfluoroalkyl-containing metal complexes (I) are new. Perfluoroalkyl-containing metal complexes of formula K1>-L(Q-R)-N(A)-X-Rf (I), are new. R : mono- or oligosaccharide bound with one hydroxy...
DE102005033099A1 New 1,4-benzothiazepine-1,1-Dioxidderivat with improved properties, process for its preparation, pharmaceuticals comprising this compound and its use  
The Invention relates to the compound of formula A and physiologically acceptable Salts. The connection is suitable for. B. as Hypolipidämikum.
DE102005032307A1 Oligomers of free fatty acids and pharmaceutical compositions containing them  
The Invention relates to novel compounds, called out. Free fatty acids derived leave. These are oligomers of at least two saturated or unsaturated free fatty acids natural, semi-synthetic or...
DE102005031755B4 Salmonella spp. binding peptides, nucleic acids encoding the Verwenduen and methods and kits for enrichment, immobilization and detection of Salmonella spp.  
Salmonella spp. binding peptide selected from the sequences SEQ ID NO. 1 to NO. 3, SEQ ID NO. 5 to NO. 8, SEQ ID NO. 10, SEQ ID NO. 12, SEQ ID NO. 14 to NO. 16, SEQ ID NO. 18, SEQ ID NO. 20 to NO....
DE102005031755B9 Salmonella spp. binding peptides, nucleic acids coding therefor, their uses, and methods and kits for the enrichment, immobilization and detection of Salmonella spp.  
Salmonella spp. binding peptide selected from the sequences SEQ ID NO. 1 to NO. 3, SEQ ID NO. 5 to NO. 8, SEQ ID NO. 10, SEQ ID NO. 12, SEQ ID NO. 14 to NO. 16, SEQ ID NO. 18, SEQ ID NO. 20 to NO....
DE102005031755A1 New peptides that bind to Salmonella, useful for immobilization, detection, concentration and labeling, optionally derivatized with a pharmaceutical  
Peptide (I) that (i) contains a segment of at least 8 amino acids from any of SEQ ID NOs (1)-(36), all reproduced, and (ii) can bind to Salmonella species is new. Independent claims are included...
DE112004002408T5 A process for obtaining an enriched population of siRNA-expressing cells  
process for obtaining cells which are capable of inhibiting RNA expressing, said method comprising: introducing at least one nucleic acid in a cell, wherein the at least one nucleic acid in the...
DE102005029998A1 Preparation of spatially resolved substance libraries, preferably polymer libraries, comprises immobilizing chemical reactions and controlling photo-sensitive precursors of activating reagent in fluidic space  
Preparation of spatially resolved substance libraries comprises immobilizing chemical reactions through spatially resolved exposure and controlling photo-sensitive precursors of the activating...
DE102005029811B4 Oligonucleotide arrays, methods for their use, and their use  
oligonucleotide arrays comprising at least two by at least one spacer linked hybridizable oligonucleotide as primer sequences, characterized in that the spacer is selected from functionalized...
DE102005029811A1 Oligonucleotide arrays, methods for their use, and their use  
The Invention relates to oligonucleotide arrays comprising respectively at least two at least a spacer linked Oligonucleotide and a method using the oligonucleotide arrays for the amplification...
DE102006012415A1 An enzymatic process for the recovery of degraded vegetable gum  
The comprises methods for the recovery of degraded vegetable gum the following phases: providing an aqueous solution of a vegetable gum at a temperature ranging between 0 and 80 ° C, the solution...
DE4323567B4 Aucubin for treating a hepatitis B virus infection  
use of Aucubin, the aglycone of Aucubin or a pharmaceutically acceptable salt or the aglycone of aucubin of aucubin for treating a hepatitis B virus infection.
DE20321227U1 New isostructural pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A useful for treating e.g. bacterial and protozoal infections  
An isostructural pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A is new and has the monoclinic space group, average unit cell parameters as given in the specification. An...
DE102006020463A1 Procedure for partial removal of nucleic acid from a liquid, which is obtained during lysis of microorganism, comprises binding selective adsorbing component that freely floats in the liquid after pre-set incubation time  
Procedure for at least partial removal of nuclei acids (18) from a liquid (12), which is obtained during the lysis of micro-organism such as bacteria, yeasts, mushrooms, protozoa or cell culture...
DE102006020463B4 A method of removing nucleic acids from a fluid, method for producing adsorber and using Membranadsorbermaterial-blend  
A method for at least partial removal of nucleic acids (18) from a liquid (12), as they occur during the digestion of microorganisms such as bacteria, yeasts, fungi, protozoa or eukaryotic cell...
DE19781703B4 Effective against tumors Anthracyclindisaccharide, fermentation processes for their preparation and therapeutic composition containing them  
connection of the formula: wherein R represents a -COCH3-, -CHOHCH3- or -COCH2OH group, and their pharmaceutically acceptable addition salts.
DE10227432B4 A process for the separation of carbohydrate carboxylic acids  
process for separating a Carbohydrate ratcarbonsäure of an aqueous dilute solution this mixture of these carbohydrate carboxylic acid and at least one other Carbohydrate carboxylic acid, wherein...
DE102005023829A1 Alleles of opcA gene from corynebacteria  
The Invention relates to mutants and alleles of the gene of coryneform opcA Bacteria encoding Variants of the OpcA subunit of glucose-6-phosphate dehydrogenase (EC: 1.1.1.49), and methods for...
DE102005023761A1 At the Lck-SH3 and Hck SH3 domain-binding peptides  
The Invention relates to the Lck-SH3 and Hck SH3 domain binding Peptides.The proteins according to the sequences 1, 2 and 4 to bind the domain Lck-SH3 and Hck SH3 on, whereby effector molecules of...
DE10228857B4 Tetraether lipids with small head groups, their preparation and use  
tetraether with small head groups of the general formula A, in R and R1, Independently of one another, 1.1. -CH2-I or -CH2-IO31.2. -CH2-Br 1.3. -CH2-ONa 1.4. - [CH2-NX3]+Wherein X is an alkane or...
DE102006020872A1 A method for nucleic acid isolation and apparatus for nucleic acid isolation  
It An object of the present invention, RNA from a nucleic acid-containing sample isolate by safe and convenient operations.As a result, detailed studies, the inventors of the present invention...
DE102005023055A1 Making DNA fragments for determining DNA methylation pattern involves digesting DNA with methylation-specific restriction enzyme; and ligating adapters to restriction fragments, followed by primer mediated-amplification of ligated fragments  
Making a selected mixture of DNA fragments involves obtaining a solution comprising genomic DNA; digesting the genomic DNA with at least one methylation-specific restriction enzyme, where the DNA...
DE10010282B4 A method for the detection of cytosine methylation in DNA samples  
process for the detection of 5-methylcytosine in genomic DNA samples, characterized in that one performs the steps of: (A) a genomic DNA from a DNA sample with a reagent Chemically speaking, with...
DE102005015832A1 Use of receptor multimerization epitope (RME) of advanced glycation end product receptor (AGER) as immunogen, useful for preparing antibodies for diagnosis and treatment of e.g. spinal injuries or diabetic complications  
Use of the receptor multimerization epitope (RME) of the advanced glycation end product receptor (AGER) as an immunogen for preparing polyclonal antiserum or monoclonal antibodies against AGER-RME...
DE102006012414A1 Chemical process for the recovery of degraded vegetable gum  
The comprises methods for the recovery of degraded vegetable gum the steps of: providing a suspension of vegetable Rubber in an aqueous alcoholic solution, which has an alcohol concentration in a...
DE102006012414B4 Chemical process for the production of degraded polygalactomannans  
A process for recovering degraded polygalactomannan comprising the steps of: providing a suspension of a polygalactomannan in an aqueous alcoholic solution having an alcohol concentration between...
DE102005019452A1 New 18-fluorine-substituted 3'-deoxythymidine derivatives, useful in positron emission tomography, particularly for detection of brain tumors  
18-Fluorine-substituted 3'-deoxythymidine derivatives (I) are new. 18-Fluorine-substituted 3'-deoxythymidine derivatives of formula (I) are new. X : hydrogen or 18-fluoro; Y : hydrogen, azido or...
DE102005015894A1 A process for preparing polyether alcohols  
object The invention provides a process for preparing polyether alcohols by catalytic addition of alkylene oxides with a starter substance mixture, containing water-soluble, solid at room...
DE102005014424A1 New surfactants and emulsifiers new on the basis of disaccharides  
compounds according to the formulaFROM)x-C,in whichA a reducing di- or trisaccharide,B is a polyhydric alcohol having 2 to 4 carbon atoms or its derivativeC is a branched or unbranched, saturated...
DE102005013258B3 A process for preparing Naringeninderivaten from xanthohumol  
The This invention relates to an efficient process for preparing of Naringeninderivaten from xanthohumol or derivatives thereof. Especially the method according to the present invention producing...
DE19948651B4 Para- and diamagnetic perfluorinated compounds containing pharmaceutical formulations, their preparation and use  
Galenic Formulation, characterized in that it comprises paramagnetic perfluoroalkyl- Compounds according to general formula I RF-A (I)where RF a straight-chain or branched perfluoroalkyl radical...
DE102005013380A1 extraction process  
The This invention relates to a process for the preparation of Tiliroside or Tiliroside-containing extracts from parts of a plant, selected from the family Sterculiaceae, corresponding extracts...